There were 20 new locally confirmed cases in Liaoning; the Chinese research team found the key factors that cause the new crown

The "medical community" evening news, do not miss every medical hotspot.

There were 20 new locally confirmed cases in Liaoning

From 0:00 to 18:00 on February 10, there were 20 new confirmed cases of local covid-19 in Liaoning Province, including 1 case reported by Shenyang City and 19 cases reported in Huludao City, and 1 new case of local asymptomatic infection was reported by Shenyang City. There are no cured and discharged cases.

As of 18:00 on February 10, the province has reported a cumulative total of 833 confirmed cases (including 173 cases imported from abroad), 807 cases cured and discharged from hospital, 2 deaths, and 24 cases treated in hospital (22 cases in china and 2 cases imported from abroad). At present, there are still 15 cases of asymptomatic infection (4 cases in china and 11 cases imported from abroad) in designated hospitals for isolation and observation. (Liaoning Health Commission)

The Chinese research team has found the key factors that cause covid-19

Recently, the research team of Professor Yu Wenqiang from the Institute of Biomedical Research of Fudan University, together with Professor Lu Hongzhou, president of the Third People's Hospital of Shenzhen and other research teams, after nearly 2 years of intensive research, found for the first time that the common sequence of the new coronavirus and humans is the key factor causing the disease, and named it "human sequence". The research team found that these common codes of the new crown virus and humans can not only activate the expression of inflammation-related genes to induce cytokine storms, but also promote the accumulation of hyaluronic acid in the body to lead to the production of new crown clinical symptoms such as pulmonary disease ground glass lesions. At present, the research results have been officially published in the sub-journal "Electronic Biomedicine" of The Lancet. (See news from Knows)

The Family Planning Association will carry out special actions to intervene in the flow of unmarried people

A few days ago, the "2022 Work Points of the China Family Planning Association" released on the official website of the China Family Planning Association mentioned that in 2022, it is necessary to implement reproductive health promotion actions, focus on solving the outstanding problems of reproductive health of adolescents, childbearing age groups and other specific groups, carry out special actions for artificial abortion intervention for unmarried people, reduce unintended pregnancies and abortions among adolescents, and improve the reproductive health level of the masses. (The Paper)

Doctors broadcast gynecological surgery to the hospital to be punished

Recently, the website of the Donggang District People's Government of Rizhao City, Shandong Province, shows that due to the violation of the medical information security system and imperfect safeguard measures, resulting in the leakage of medical information, the Rizhao Donggang District Health and Health Bureau issued a warning and a fine of 50,000 yuan to the Rizhao Central Hospital.

Previously, the hospital's doctor Li Moumou broadcast gynecological surgery live on the Internet, was criminally detained, submitted for arrest, and cancelled the qualification certificate of practicing physicians in accordance with laws and regulations and expelled. The 11 relevant personnel with leadership responsibilities and direct management responsibilities of the Rizhao Donggang District Government, the Rizhao Donggang District Health Bureau, and the hospitals involved were seriously held accountable, and those with direct management responsibilities and important leadership responsibilities were dismissed. (China News Network)

Promote the high-quality development of public hospitals

Evaluation indicators (trial) were released

In order to grasp the implementation of the Opinions of the General Office of the State Council on Promoting the High-quality Development of Public Hospitals (Guo Ban Fa [2021] No. 18), the Secretariat of the State Council Medical Reform Leading Group established an evaluation mechanism for promoting the high-quality development of public hospitals. The evaluation indicators for promoting the high-quality development of public hospitals are formulated by the Secretariat of the Leading Group for Medical Reform of the State Council, including eight first-level indicators and 27 second-level indicators such as leading the new trend of high-quality development of public hospitals. The Secretariat of the State Council Medical Reform Leading Group will evaluate the high-quality development of public hospitals in various provinces (autonomous regions and municipalities) every year. (National Health Commission)

Two towns in Guangxi issued a notice: Reports were made to those who had not reported their returnees

Reward 1 chicken or $200

On February 8 and 9, Jiangping Town and Dongxing Town, Dongxing City, Guangxi Zhuang Autonomous Region, issued announcements successively, calling on the public to actively report returnees from outside the city, especially those who did not report in advance in the return of medium- and high-risk areas, and the reward for Jiangping Town was a local chicken, and the reward for Dongxing Town was 200 yuan. (Upstream News)

The first CAR-T therapeutic monograph in China came out

Recently, Professor Huang He, president of the First Affiliated Hospital of Zhejiang University School of Medicine and leader of bone marrow transplantation, professor Xu Kailin of the Affiliated Hospital of Xuzhou Medical University, and Professor Zhou Jianfeng of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology edited the first CAR-T therapeutic monograph - "CAR-T Cell Immunotherapy", published by the People's Medical Publishing House.

"CAR-T Cell Immunotherapy" is the first CAR-T therapeutic monograph in China that integrates experts in the fields of clinical medicine and life sciences, which summarizes the vast literature and innovative clinical research results in the development process of this field, and provides scientific support and theoretical basis for the establishment of a standardized CAR-T cell research and development and clinical research system. (School of Medicine, Zhejiang University)

Source: Medical community comprehensive collation

Editor-in-charge: Zheng Huaju

Proofreader: Zang Hengjia

Plate making: Xue Jiao